Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2774
Peer-review started: October 23, 2023
First decision: November 8, 2023
Revised: November 20, 2023
Accepted: December 1, 2023
Article in press: December 1, 2023
Published online: December 27, 2023
Processing time: 65 Days and 9.9 Hours
Rectal carcinoma (RC) treatment primarily involves laparoscopic surgery, which may induce significant hemodynamic changes and weaken immune function. Certain anesthetic approaches using opioid drugs (including remifentanil and sufentanil) pose risks, such as hypotension.
To determine the effects of remifentanil combined with propofol on hemodynamics and oxidative stress in patients undergoing RC resection.
A total of 211 patients one hundred and four patients with RC treated at the First Affiliated Hospital of Dalian Medical University between November 2018 and November 2022 were retrospectively analyzed. Among them, the remifentanil group included 45 patients receiving remifentanil with propofol anesthesia and the sufentanil group included 59 patients receiving sufentanil with propofol anesthesia. Changes in the hemodynamic index, oxidative stress index, general data, consumption of remifentanil, and use of vasoactive drugs were compared. The incidences of adverse reactions were calculated.
The two groups did not significantly differ in terms of operation, anesthesia, and extubation times (P > 0.05). At 1 min after intubation, the sufentanil group showed a notably higher heart rate, systolic blood pressure (SBP), diastolic blood pressure, and mean arterial pressure (MAP) compared with the remifentanil group (P < 0.05), whereas the sufentanil group showed a notably higher SBP and MAP compared with the remifentanil group at 5 min after pneumoperitoneum (P < 0.05). Thirty minutes after surgery, the remifentanil group showed significantly lower plasma cortisol, noradrenaline, and glucose levels than the sufentanil group (P < 0.001). The remifentanil group consumed significantly less remifentanil than the sufentanil group (P < 0.05), and the adoption frequency of ephedrine was lower in the remifentanil group than that in the sufentanil group (P < 0.05). The incidence of hypotension was notably higher in the sufentanil group than that in the remifentanil group (P < 0.05).
Remifentanil combined with propofol can improve hemodynamics and relieve oxidative stress in patients undergoing RC resection.
Core Tip: This study evaluated the effects of remifentanil combined with propofol on the hemodynamics and oxidative stress in patients undergoing rectal carcinoma surgery. These findings indicate that this combination improves hemodynamic stability, reduces oxidative stress, and results in a lower incidence of hypotension compared with sufentanil alone. Furthermore, the remifentanil-propofol combination requires less remifentanil consumption and reduced use of ephedrine, suggesting that it is a more effective and potentially safer anesthetic approach for these surgeries.